Verisense announce opening of Digital Biobank
Natalia Elliot | August 14, 2024 | News story | Research and Development | AI, Devices, Diagnostics, Verisense, artificial intelligence, digital health, machine learning
This week, Verisense have announced that their Digital Biobank, with data from over one million people, is open for business.
The data and digital health technology company have launched their Digital Biobank which will include data from both third parties and Verisense Health Research, totaling 570 studies.
Verisense CEO Geoff Gill stated: “For too long, digital health data from thousands of studies from around the world have been virtually impossible to access. As a result, researchers have had to collect the same or similar data over and over at great cost in time and money.”
The Digital Biobank includes specific medical data which can be used to identify algorithms and digital biomarkers, allowing for comparisons between data to show emerging trends for specific diseases. The data collected come from measurements such as heart rate, respiration, blood pressure, accelerometry, electrocardiogram photoplethysmography, polysomnography, electromyography, electrooculography and galvanic skin response sensors.
“Our goal is for researchers never to have to collect the same data twice,” Geof Gill added
The Digital Biobank utilises an AI-powered Dataset Cataloger, which extracts and catalogues relevant metadata in an efficient manner from open-source digital health datasets. The AI Dataset Cataloger is an automated the process, enabling Verisense Health to update the Verisense Digital Biobank frequently.
Natalia Elliot
Related Content
Cellbyte raises $2.75m to fund pharma drug launch platform
Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of …
MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding
MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), …
Sanome’s AI tool gains certification for early detection of hospital infections
Sanome’s MEMORI, an artificial intelligence (AI) medical device that can predict hospital-acquired infections up to …
